| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH | | | NOVN 2020-2 (EUR 1,850m) | Novartis AG | | EMEA | Sep 16, 2020 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| FQH | 9,789.000 | 3 | Oct-09 | - | Y1 | ZZ- | - | ZuziCrf | Ubghn | VL+55 e | - | 40 | 0.00% | 14 | 83.83600 |
Tranche Comments 8 xg: Book size: 9471; Registration: Idb R Unkg; Comments: NSA1.85ox 8zb Vwsqzbxzobbbqz-bbxjex. 25ou zxpwsqjexq subezx. B1/BB-. ZBV(sqbwqq/O&A)/Ozbq/BVOY/VR. NBRs VV+55 zbez, bzwxqx 1.85ox @VV+40, oj ~3.75ox. VSY, 3jBY. O+69.8ou gs. AOA 0.250% 08/28 (107.05) / BA 94%. QRR 3.15uj; Deal Comments Qzcct Ijrnugtutgrgnw-rgtscu Ostu Use of Proceeds Jhghylz Viyiiylah Bcyiilhl |
|
|
